United States · FDA National Drug Code directory
SIROLIMUS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-316_27e377c2-1e6a-d4e2-e063-6394a90a2812
- Product NDC
- 31722-316
- Form
- SOLUTION
- Composition / generic term
- Sirolimus
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240916
- Source listing expiry
- 20261231
Source-listed ingredients
- SIROLIMUS — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTON in 1 KIT (31722-316-31) / 1 BOTTLE, GLASS in 1 CARTON (31722-316-60) / 60 mL in 1 BOTTLE, GLASS · 31722-316-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →